[Protective effect of recombinant HMGB1 A box protein in mouse with acute hepatic failure].
To evaluate the effect of recombinant HMGB1 A box protein in mouse with acute hepatic failure. Acute hepatic failure was induced by D-galactosamine and lipopolysaccharide in mice. After injection with saline (control) or recombinant HMGB1 A box proteins, the expression of HMGB1 in liver tissues was detected by immunohistochemistry and RT-PCR, and the serum TNFalpha and IL-1beta were quantified. rHMGB1-Abox protein alleviated the acute liver damage. rHMGB1-Abox protein treatment decreased the expression of HMGB1 in liver tissues and reduced the serum levels of TNFalpha and IL-1beta. rHMGB1-Abox protein can alleviate the acute liver damage and inhibit the expression of HMGB1.